Form D · Biotechnology
Eccrine Systems, Inc.
Cincinnati, OH · CIK 0001677374
Offering snapshot reported Oct 18, 2019 · SEC filing
- Reported sold
- $1.87M Offering amount: $4.4M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 4, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 18, 2019 | Initial | $1,868,501 | No comparison | 8 | SEC filing |
| Jul 3, 2019 | Initial | $621,949 | No comparison | 5 | SEC filing |
| Jul 11, 2018 | Initial | $6,626,600 | No comparison | 14 | SEC filing |
| Jul 25, 2017 | Initial | $861,504 | No comparison | 7 | SEC filing |
| Jun 28, 2016 | Initial | $4,564,787 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-351353
Source: Form D, filed Oct 18, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Patterson Beech | Director |
| Gavi Begtrup | Director, Executive |
| Chad Clark | Executive |
| Richard D. Egan | Executive |
| Keith Grimes | Executive |
| Jason Charles Heikenfeld | Director, Executive |
| John M. Rice | Director |
| Joseph E. Stigler | Director |
| Mark Tierney | Executive |
| Kara Fay Uchtman | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1775 Mentor Avenue, Third Floor
Cincinnati, OH, 45212
Cincinnati, OH, 45212